Potential selection bias in a community-based study of PSA levels in African-American men

Journal of Clinical Epidemiology

Volumn 54, Issue 2, 2001, Pages 142-148

  Heeringa, Steven G ^a   Alcser, Kirsten H ^a   Doerr, Kay ^a   Strawderman, Myla ^b   Cooney, Kathleen ^b   Medbery, Bruce ^a   Schottenfeld, David ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

African Americans; Community based survey; PSA screening; Selection bias

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ETHNIC GROUP; FAMILY HISTORY; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PRIORITY JOURNAL; PROSTATE CANCER; REGRESSION ANALYSIS; RISK FACTOR; SYMPTOM; UROLOGIC EXAMINATION;

ADULT; AFRICAN AMERICANS; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE DISTRIBUTION; AGED; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MALE; MICHIGAN; MIDDLE AGED; PHYSICAL EXAMINATION; POPULATION SURVEILLANCE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SAMPLING STUDIES; SELECTION BIAS;

EID: 0035146126     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(00)00270-5     Document Type: Article

References (32)

1. Cancer surveillance series; interpreting trends in prostate cancer-Part I: evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates
2. Serum prostate-specific antigen in a community-based population of healthy men; establishment of age-specific reference ranges
3. Age-specific reference ranges for serum prostate-specific antigen in black men
4. Reference ranges for serum prostate-specific antigen in black and white men without cancer
5. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease; a prospective multicenter clinical trial
6. Determination of prostate volume by transrectal ultrasound
7. Selection bias in epidemiologic studies
8. Differences between respondents and non-respondents in a morbidity survey involving clinical examination
9. A comparison between participants and non-participants in a primary preventive trial
10. Response bias in the Honolulu Heart Program
11. Some methodological problems in the long-term study of cardiovascular disease; observations on the Framingham Study
12. Response and follow-up bias in cohort studies
13. Non-participation and mortality in a prospective study of cardiovascular disease
14. Participation in a follow-up study of health among unemployed and employed people after a company closedown; drop outs and selection bias
15. Nonresponse and intensity of follow-up in an epidemiologic study of Vietnam-era veterans
16. Cardia; study design, recruitment, and some characteristics of the examined subjects
17. The Atherosclerosis Risk in Communities (ARIC) Study; design and objectives
18. The prevalence of prostatism; a population-based survey of urinary symptoms
19. Differences between respondents and non-respondents in a population-based cardiovascular disease study
20. Difficult-to-recruit respondents and their effect on prevalence estimates in an epidemiologic survey
21. Recruiting black men to a clinical trial to evaluate prostate cancer screening-Detroit, Michigan, 1998
22. Recruiting minority cancer patients into cancer clinical trials; a pilot project involving the Eastern Cooperative Oncology Group and the National Medical Association
23. Demographics, family histories, and psychological characteristics of prostate carcinoma screening participants
24. Urinary symptoms as a predictor for participation in prostate cancer screening among African American men
25. Predictors of interest in prostate-specific antigen screening and the impact of informed consent; what should we tell our patients?
26. Familial prostate cancer in Sweden; a nationwide register cohort study
27. Prostate-specific antigen (PSA) best practice policy